Insider Transactions in Q1 2021 at Viela Bio, Inc. (VIE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Astrazeneca PLC > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
14,650,334
-100.0%
|
$776,467,702
$53.0 P/Share
|
|
Mar 13
2021
|
Yanling Cao Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
8,322,353
-100.0%
|
$441,084,709
$53.0 P/Share
|
|
Mar 13
2021
|
Zhengbin Yao Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
200,000
-100.0%
|
$10,600,000
$53.0 P/Share
|
|
Mar 13
2021
|
Zhengbin Yao Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
270,219
-100.0%
|
$14,321,607
$53.0 P/Share
|
|
Mar 13
2021
|
William Ragatz Senior VP, Head of Commercial |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,250
-100.0%
|
$861,250
$53.0 P/Share
|
|
Mar 13
2021
|
Jorn Drappa Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
202,661
-100.0%
|
$10,741,033
$53.0 P/Share
|
|
Mar 13
2021
|
Mitchell Chan Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,500
-100.0%
|
$1,987,500
$53.0 P/Share
|
|
Mar 13
2021
|
Boundless Meadow LTD > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
300,000
-100.0%
|
$15,900,000
$53.0 P/Share
|
|
Mar 13
2021
|
Boundless Meadow LTD > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,322,353
-100.0%
|
$441,084,709
$53.0 P/Share
|
|
Mar 13
2021
|
Edward Hu Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,161,177
-100.0%
|
$220,542,381
$53.0 P/Share
|
|
Mar 13
2021
|
Andreas Wicki Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,750,000
-100.0%
|
$92,750,000
$53.0 P/Share
|